Skip to content

Clinicians' Corner

Brought to you by LEO Pharma, the Clinicians' Corner provides educational resources on patient burden and the pathophysiology behind AD. Discover more about AD from leading experts on this complex and chronic disease.
Experts have been compensated for their time and effort.

Atopic Dermatitis Experts

Heterogeneity and treatment options

AD is a heterogeneous disease with an unmet need for long-term disease control

Watch video

AD treatment: The need for multiple options

Knowing that flare-ups are inevitable, having multiple options empowers the patient to be an active participant in the treatment decision-making.

Watch video

Jonathan Silverberg, MD, PhD, MPH

Professor, Department of Dermatology 
Director of Clinical Research, Director of Patch Testing
George Washington University, Washington, DC

“Getting to the Bottom of AD – Is It One Disease, or Many Diseases?”

Current View of AD: The Many Burdens of Atopic Dermatitis

Shifting the Focus: A Heterogeneous Disease in a Heterogeneous Population

See presentation

Potential Implications for Future AD Management

See presentation

Looking Deeper: Complex Pathophysiology, but Is It Possible to Focus on One Key Mechanism?

See presentation